PRODUCT COMMERCIALIZATION AGREEMENTProduct Commercialization Agreement • October 13th, 2020 • California
Contract Type FiledOctober 13th, 2020 JurisdictionThis Product Commercialization Agreement is a legally binding contract between MINDFULL PRODUCTS (sometimes referred to as “Us” or We”) and the Product Developer(s) listed above (sometimes referred to as “You”) with regard to the Product identified above. This Agreement governs the relationship between You and MINDFULL PRODUCTS in terms of how We will go about commercializing the Product, how (and when) You will be paid, who owns what, and other stuff the lawyers insisted We say. You and any Co-Developers should read it carefully before signing this Agreement.
PRODUCT COMMERCIALIZATION AGREEMENTProduct Commercialization Agreement • November 2nd, 2009 • Valeant Pharmaceuticals International • Pharmaceutical preparations
Contract Type FiledNovember 2nd, 2009 Company IndustryThis Product Commercialization Agreement (this “Agreement”) is entered into by and between Mylan Pharmaceuticals Inc. (“Mylan”), a West Virginia corporation having its corporate offices at 781 Chestnut Ridge, Morgantown, West Virginia, 26505 and Dow Pharmaceutical Sciences, Inc. (“DPSI”), a Delaware corporation having its corporate offices at 1330 Redwood Way, Petaluma, California, 94954-1169.